NCT04118062View on ClinicalTrials.gov

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2024

Conditions
Metastatic Uveal MelanomaTriple Negative Breast CancerLuminal B Breast CancerPediatric Cancer
Interventions
BEHAVIORAL

Questionnaires

Questionnaires

BEHAVIORAL

Semi-structured individual interviews

Semi-structured individual interviews

OTHER

Focus Group

Focus Group

OTHER

DELPHI Consensus Method

DELPHI Consensus Method

Trial Locations (1)

75005

Institut Curie, Paris

All Listed Sponsors
lead

Institut Curie

OTHER

NCT04118062 - Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR) | Biotech Hunter | Biotech Hunter